sinc
first
descript
recombin
dna
techniqu
mani
advanc
achiev
field
molecular
biolog
genet
modif
current
wide
varieti
tool
allow
genet
modif
anim
plant
bacteria
virus
genet
modif
virus
becom
one
best
strategi
introduc
nucleic
acid
differ
cell
tissu
even
vivo
model
given
high
transfect
effici
eas
carri
compar
chemic
physiolog
method
descript
recombin
event
cell
infect
vaccinia
viru
vacv
recombin
dna
technolog
vacv
becom
suitabl
model
gener
recombin
viru
vector
first
main
purpos
introduc
foreign
gene
viru
genom
basic
research
biolog
virus
vitro
vivo
howev
latest
technic
advanc
higher
understand
vacv
viral
cycl
viru
genet
modif
get
wider
spectrum
purpos
thu
also
use
develop
vaccin
oncolyt
agent
review
aim
highlight
main
aspect
genet
modif
vacv
gener
applic
reporterexpress
viru
model
vacv
prototyp
member
poxvirida
famili
research
poxviru
focus
use
vacv
larg
dna
doublestrand
viru
complex
envelop
live
vaccin
use
erad
smallpox
nowaday
also
use
viral
vector
recombin
vaccin
cancer
therapi
vacv
genom
one
largest
dna
virus
size
kbp
encod
gene
genom
high
genet
compact
intergen
small
noncod
region
code
region
continu
therebi
given
splice
vacv
complet
replic
cycl
insid
cytoplasm
host
cell
even
though
dna
viru
figur
fact
determin
genet
characterist
viru
complet
independ
replic
transcript
machineri
host
cell
virion
infect
host
cell
viral
core
uncoat
nearli
earli
viral
gene
transcrib
earli
gene
produc
requir
enzym
catalyz
viral
core
breakdown
viral
dna
replic
modul
host
antivir
respons
viral
dna
begin
replic
insid
infect
host
cell
use
viral
enzym
h
postinfect
soon
viral
replic
start
transcript
downstream
gene
encod
regulatori
protein
induc
express
late
gene
occur
late
gene
encod
protein
enzym
requir
assembl
new
viral
particl
dna
viral
protein
synthes
process
known
morphogenesi
begin
result
format
new
virion
retain
insid
cell
cellular
lysi
releas
environ
mechan
sever
featur
biolog
vacv
make
suitabl
use
vector
biolog
experi
vaccin
design
cancer
therapi
complet
cytoplasm
replic
vacv
facilit
express
foreign
gene
insert
viral
genom
detect
isol
usual
bacteri
nonmammalian
viral
vector
fail
make
express
protein
perform
full
activ
antigen
howev
vacv
abil
transcrib
gene
use
transcript
factor
enzym
mean
foreign
gene
insert
directli
vacv
promot
element
transcrib
foreign
protein
reach
high
level
express
infect
cell
moreov
replic
cycl
appropri
model
molecular
genet
investig
ci
tran
factor
mainli
requir
gene
express
furthermor
sinc
vacv
remain
cytoplasm
risk
insert
mutagenesi
oncogenesi
main
problem
encount
gene
therapi
use
integr
virus
disappear
case
patient
treat
retrovir
vector
develop
cancer
year
treat
vacv
replic
differ
cell
line
primari
cell
cultur
also
grow
sever
anim
speci
mice
guinea
pig
rabbit
etc
broad
host
rang
allow
infect
cell
line
recombin
virus
largescal
express
heterolog
protein
reduc
cost
comparison
product
system
addit
vacv
enabl
high
product
titer
advantag
manufactur
larg
amount
vaccin
although
vacv
genom
larg
compact
toler
delet
certain
viral
sequenc
insert
exogen
genet
materi
vacv
vector
transgen
capac
approxim
kb
higher
viral
vector
includ
adenoassoci
viru
kb
adenoviru
kb
retroviru
kb
thu
vacv
excel
candid
vector
design
polyval
vaccin
antigen
sever
pathogen
differ
antigen
pathogen
final
far
use
vaccin
vector
concern
vacv
clearli
immunogen
effect
strong
evid
erad
smallpox
vacv
also
safe
easi
inocul
sinc
administr
intraderm
air
gun
without
medic
train
organ
found
caus
problem
preexist
immun
probabl
postvaccin
complic
progress
vacv
infect
enceph
significantli
low
nowaday
due
better
knowledg
vacv
biolog
immun
respons
gener
vaccin
vaccin
base
viru
becom
safer
addit
import
remark
vacv
vector
stabl
lyophil
kept
frozen
sever
year
facilit
transport
storag
vacv
genom
seven
known
insert
site
foreign
gene
insert
figur
insert
site
choic
depend
mainli
futur
applic
recombin
virus
may
also
import
later
select
recombin
virus
obtain
instanc
insert
gene
interest
thymidin
kinas
tk
locu
confer
detect
phenotyp
tk
recombin
virus
abl
grow
presenc
deoxyuridin
brdu
synthet
analog
thymidin
anoth
import
site
insert
allow
subsequ
select
vacv
hemagglutinin
ha
gene
recombin
virus
easili
recogn
disabl
bind
erythrocyt
hemagglutin
test
vacv
five
place
insert
bamhi
site
hindiiif
dna
fragment
vacv
growth
factor
gene
vgf
locat
invert
termin
repeat
itr
gene
locat
left
side
vacv
genom
subunit
ribonucleotid
reductas
rr
gene
hindiiii
dna
fragment
gene
encod
kda
fusion
protein
larg
hindiiia
dna
fragment
noteworthi
strain
vacv
one
copi
vfg
vacv
lister
variant
recombin
product
use
insert
site
although
success
occur
requir
use
marker
gene
strategi
later
select
recombin
virus
due
limit
tk
gene
common
site
insert
vacv
genom
author
use
temperaturesensit
vacv
strain
allow
recombin
virus
select
cultur
howev
common
way
easi
identif
recombin
virus
use
report
gene
select
marker
discuss
section
spite
promot
region
promot
code
region
insert
site
also
influenc
foreign
gene
express
viru
virul
insert
tk
vgf
rr
gene
impact
viral
replic
vivo
vitro
moreov
method
describ
figur
requir
use
special
cell
line
mutagen
select
agent
tk
cell
line
brdu
reason
differ
strategi
new
insert
site
studi
ensur
correct
express
transgen
vitro
vivo
cat
first
report
gene
use
transcript
assay
mammalian
cell
cat
enzym
escherichia
coli
detoxifi
antibiot
chloramphenicol
inhibit
protein
synthesi
bacteria
particularli
cat
link
acetylcoenzym
acetylcoa
group
chloramphenicol
prevent
block
ribosom
subunit
gene
found
eukaryot
eukaryot
cell
present
basal
cat
activ
reaction
catalyz
cat
quantifi
use
fluorogen
radiolabel
substrat
acetylcoa
chloramphenicol
cat
detect
either
thinlay
chromatographi
autoradiographi
enzymelink
immunosorb
assay
elisa
strong
link
cat
gene
transcript
level
enzymat
activ
easi
quantifi
thu
cat
becom
suitabl
report
gene
investig
transcript
element
wide
varieti
experi
implic
anim
plant
cell
well
virus
disadvantag
use
cat
system
higher
amount
cell
requir
compar
assay
like
luciferas
assay
detail
section
addit
cat
system
suitabl
use
weaklyexpress
gene
cat
promot
activ
quantif
take
longer
report
system
final
report
gene
anoth
import
limit
due
use
radioisotop
first
studi
use
lacz
report
gene
publish
sinc
becom
one
commonlyus
report
gene
molecular
biolog
although
catalyz
cleavag
disaccharid
lactos
form
glucos
galactos
recogn
sever
artifici
substrat
promot
use
report
gene
thu
hydrolyz
substrat
orthonitrophenyl
betagalactosid
onpg
betadgalactopyranosid
xgal
betadgalactopyranosid
sgal
result
yellow
blue
black
product
precipit
respect
furthermor
express
lacz
gene
stimul
isopropyl
betadthiogalactopyranosid
iptg
highli
stabl
synthet
nonhydrolyz
analog
lactos
one
applic
lacz
report
gene
select
transform
bacteri
coloni
recombin
white
nonrecombin
blue
bacteria
discrimin
base
interrupt
lacz
gene
insert
dna
gene
interest
use
xgal
substrat
use
visual
express
transfect
eukaryot
cell
select
recombin
viru
viral
plaqu
screen
final
lacz
use
detect
activ
immunolog
histochem
experi
one
main
advantag
use
report
gene
system
low
cost
sinc
requir
specif
devic
detect
colorimetr
reaction
identifi
express
anoth
escherichia
colideriv
hydrolyz
enzym
gene
lend
report
assay
gu
protein
catalyz
breakdown
complex
carbohydr
glycosaminoglycan
report
gene
system
wide
use
transgen
plant
also
success
use
mammalian
cell
vacv
recombin
viru
select
gu
assay
betadglucuronid
mug
betadglucuronid
xgluc
use
substrat
respect
lead
fluorogen
blue
product
cleavag
monitor
activ
gu
assay
allow
determin
spatial
tempor
express
gene
interest
known
fluoresc
protein
green
fluoresc
protein
gfp
clone
speci
jellyfish
aequorea
victoria
great
impact
fluoresc
protein
molecular
biolog
applic
nobel
prize
chemistri
award
osamu
shimomura
martin
chalfi
roger
tsien
discoveri
develop
gfp
gfp
use
report
gene
howev
genet
engin
develop
wide
varieti
color
mutant
red
fluoresc
protein
rfp
yellow
fluoresc
protein
yfp
among
other
fluoresc
protein
toler
n
ctermin
fusion
widerang
protein
express
known
cell
type
use
nonharm
fluoresc
marker
live
cell
organ
use
fluoresc
protein
allow
varieti
applic
cell
lineag
tracker
report
gene
express
assay
measur
proteinprotein
interact
addit
cellfix
need
examin
express
probabl
artifact
quit
small
compar
immunocytochem
method
requir
cell
fixat
one
disadvantag
protein
size
therefor
case
affect
vivo
function
fuse
protein
gene
interest
nevertheless
one
limit
use
gfp
low
sensit
anoth
signal
exogen
amplifi
first
luciferas
luc
firefli
photinu
pyrali
clone
luc
wide
use
report
gene
later
also
describ
bacteria
dinoflagel
luciferas
enzym
catalyz
chemic
reaction
result
product
light
firefli
luciferas
oxid
dluciferin
presenc
oxygen
adenosin
triphosph
atp
energi
sourc
assay
exogen
substrat
need
may
disadvantag
system
luciferas
identifi
bacteria
luxcdab
operon
enzym
catalyz
oxid
longchain
aldehyd
flavin
mononucleotid
presenc
oxygen
yield
greenblu
light
although
bacteria
operon
encod
compon
necessari
light
emiss
limit
mammalian
cell
therefor
exogen
substrat
ad
improv
reaction
besid
differ
substrat
requir
luciferas
system
categor
specif
kinet
particular
detect
sensit
requir
adjust
experiment
design
use
luciferas
extrem
widespread
biolog
system
studi
includ
cell
prolifer
assay
protein
foldingsecret
analys
vivo
imag
control
vivo
viral
spread
main
advantag
use
system
high
sensit
compar
system
cat
addit
luc
system
direct
rapid
suitabl
come
weaklyexpress
gene
use
quantifi
gene
activ
one
disadvantag
luc
system
requir
ultrasensit
chargecoupl
devic
ccd
camera
detect
gene
express
reportergen
assay
help
pox
virologist
basic
research
exampl
studi
locat
structur
function
mani
vacv
protein
infect
cycl
interact
protein
host
cell
shown
dvoracek
shor
gu
report
gene
use
delet
viral
protein
select
recombin
virus
aim
understand
role
protein
viral
life
cycl
addit
lacz
gene
typic
use
mainli
select
recombin
moreov
sever
studi
report
differ
transgen
insert
point
vacv
promot
recombin
viru
product
enhanc
studi
essenti
improv
develop
vaccin
base
recombin
vacv
hand
fluoresc
marker
gfp
yfp
luciferas
also
use
label
vacv
replic
strain
virus
allow
studi
process
like
input
output
morphogenesi
virusinfect
cell
studi
fluoresc
certain
viral
protein
allow
us
studi
interact
viral
cellular
protein
furthermor
vacv
clear
exampl
virus
develop
strategi
evad
immun
respons
field
gener
recombin
vacv
report
gene
also
use
discern
molecular
mechan
vacv
protein
manipul
immun
system
host
thu
unterholzn
et
al
gener
gfplabel
recombin
vacv
reveal
viral
protein
act
immunomodulatori
agent
block
express
type
interferon
anoth
major
applic
reporterexpress
vacv
design
highthroughput
assay
gener
lacz
gfp
express
recombin
viru
use
optim
antibodi
neutral
assay
lastli
vacv
report
gene
use
studi
protein
virus
particularli
rna
virus
influenza
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
genet
modifi
virus
rna
must
revers
transcrib
cdna
sinc
particularli
unstabl
plasmid
make
vacv
good
tool
function
studi
protein
virus
sever
vivo
applic
recombin
reporterexpress
virus
exampl
virul
studi
use
label
virus
allow
us
follow
viral
pathogen
detect
organ
viral
replic
dissemin
occur
exampl
zaitseva
et
al
use
recombin
vacv
western
revers
strain
wr
luc
analyz
viral
spread
vivo
sever
day
reduc
number
mice
use
moreov
vacv
effect
enhanc
humor
cellmedi
immun
use
vector
studi
immun
system
express
protein
antigen
pathogen
furthermor
vacv
use
explor
immunopatholog
mechan
know
epitop
antigen
present
pathogen
abil
induc
hostimmun
respons
demonstr
specif
role
particular
antigen
pathogen
process
despit
exampl
mention
common
use
recombin
vacv
vivo
product
prophylact
vaccin
treatment
cancer
tabl
show
vaccin
base
vacv
report
gene
insert
site
employ
indic
case
vaccin
vacv
act
vector
capabl
deliv
antigen
organ
mani
recombin
vaccin
viral
antigen
insert
also
develop
bacteria
protist
vaccin
simul
infect
pathogen
antigen
elicit
immun
respons
produc
antigen
differ
pathogen
sever
vaccin
mainli
human
immunodefici
viru
hiv
influenza
gene
immunomodulatori
cytokin
ad
coexpress
antigen
improv
immunogen
vaccin
summar
tabl
transgen
insert
site
within
tk
ha
gene
make
select
recombin
easier
explain
howev
sever
vaccin
besid
use
strategi
report
gene
use
well
use
report
gene
facilit
preliminari
test
vaccin
anim
model
moreov
especi
vaccin
use
anim
report
gene
make
possibl
distinguish
vaccin
infect
anim
exampl
vacv
use
nearli
twenti
year
erad
rabi
wildlif
oralbas
vaccin
case
recombin
vacv
express
rabi
viru
glycoprotein
use
vaccin
raccoon
red
fox
skunk
coyot
unit
state
europ
battl
success
purg
rabi
part
europ
unit
state
anoth
applic
vacv
vector
cancer
treatment
known
oncolyt
virotherapi
use
replicationcompet
virus
select
attack
destroy
cancer
cell
without
harm
healthi
host
cell
exampl
recombin
vacv
use
summar
tabl
promis
studi
use
oncolyt
vacv
vector
human
sodium
iodid
symport
hni
gene
prostat
cancer
therapi
demonstr
restrict
tumor
growth
increas
surviv
mice
vacv
also
promis
therapeut
agent
pancreat
cancer
cholangiocarcinoma
colorect
cancer
worth
mention
mani
viral
vector
develop
treat
tumor
sever
common
characterist
gener
vacv
oncolyt
vector
delet
tk
gene
essenti
pyrimidin
synthesi
pathway
forc
viru
replic
cell
display
high
amount
nucleotid
pool
enhanc
viral
tropism
cancer
cell
other
delet
vgf
gene
prevent
noninfect
cell
prolifer
furthermor
develop
vaccin
viral
vector
arm
gene
enhanc
antitumor
activ
viru
tropism
immunoreact
promot
better
tumor
destruct
granulocytemacrophag
colonystimul
factor
gmcsf
erythropoietin
gene
enhanc
viru
tabl
anoth
particular
featur
mani
recombin
carri
report
gene
thu
viral
replic
monitor
noninvas
imag
method
main
limit
use
vacv
vector
shortterm
gene
express
sinc
lytic
viru
kill
infect
cell
thu
gene
express
last
h
postinfect
addit
although
applic
advantag
sinc
vacv
replic
complet
infect
cell
cytoplasm
hard
use
vacv
engin
nuclear
gene
replac
main
disadvantag
limit
immunogen
individu
vaccin
smallpox
preexist
immun
reduc
effect
vaccin
base
vacv
although
trial
overcom
problem
mucos
vaccin
vaccinia
vector
vacv
safeti
profil
consid
progress
complic
especi
immunocompromis
individu
limit
primarili
affect
vivo
applic
vacv
recombin
vaccin
develop
sever
attenu
strain
vacv
gener
virus
develop
vaccin
oncolyt
therapi
base
vacv
requir
understand
pathogenesi
biolog
despit
improv
vector
design
use
differ
promot
insert
site
homolog
recombin
almost
exclus
way
obtain
vacv
recombin
homolog
recombin
requir
use
marker
report
gene
select
recombin
offer
mani
disadvantag
apart
physic
space
need
marker
gene
limit
therapeut
viru
use
certain
marker
introduc
mutat
gener
artifact
found
analysi
gener
viru
sometim
problem
detect
vitro
import
overcom
vector
use
vivo
anim
model
recent
year
strategi
develop
avoid
risk
use
marker
least
remov
final
recombin
vacv
rice
colleagu
describ
doubl
select
method
improv
select
recombin
vacv
report
marker
gene
necessari
helper
viru
use
rescu
recombin
vacv
subsequ
grown
nonpermiss
cell
helper
viru
allow
select
larg
percentag
recombin
virion
howev
method
certainli
enorm
import
modif
genom
cluster
regularli
interspac
short
palindrom
repeat
crispr
crisprassoci
protein
system
briefli
system
consist
endonucleas
employ
guid
rna
gener
break
target
place
genom
later
repair
either
randomli
precis
use
specif
design
rest
templat
effect
system
proven
differ
organ
includ
virus
herp
simplex
viru
hsv
hepat
b
viru
hbv
hiv
current
techniqu
start
use
also
vacv
exampl
system
achiev
delet
vacv
virul
gene
vacv
intracellular
protein
inhibit
nuclear
factorkappa
b
nfkb
activ
undesir
present
vacv
vector
therapeut
purpos
furthermor
given
effici
method
repar
vector
excis
marker
gene
design
therefor
recombin
virus
effect
isol
eventu
marker
gene
elimin
given
simplic
recombin
vacv
system
gener
exponenti
increas
applic
better
marker
basic
research
without
select
marker
clinic
applic
expect
conclus
develop
recombin
virus
promis
therapeut
advanc
biomed
field
sens
use
reporterexpress
vacv
becom
fundament
tool
number
applic
basic
research
vaccin
design
cancer
therapi
mani
trial
still
experiment
inform
requir
regard
side
effect
viral
treatment
continu
effort
necessari
develop
new
reporterexpress
vacv
safer
effect
futur
therapi
